Radiation
Injury Drugs Market Revenue, Industry Growing Demand, Regional Outlook Up To
2031

The
global radiation injury drugs market is anticipated to grow at a significant
CAGR 4.5% during the forecast period (2024-2031). Radiation injury is
defined as the damage of tissues due to exposure of ionizing radiation. The
ionizing radiation given in large dose may injure the healthy human cells and
even result in acute illness leading to decrease in the production of blood cells
and harm the gastrointestinal tract. It also results in the damage to
cardiovascular health, blood vessels, brain and especially skin. The major
factor attributable to the market growth include the high prevalence of cancer
patients globally who further opt for the radiation therapy. For instance, as
per the International Agency for Research on Cancer, in 2020, there were 19.3
million cases of cancer globally and 10 million died due to cancer. Thus, this
surge in the cancer patients is likely to drive the global radiation injury
drugs market growth. 

Get Free Sample link @ https://www.omrglobal.com/request-sample/radiation-injury-drugs-market

In
addition to this, various enduring research and products under clinical trials
are the factors for the growth of radiation injury drug market. For instance,
BioMimetix drug BX-001 is under clinical phase II trial and is used for the
patients with high-grade glioma. However, the drug is also used to provide
protection against the damage or injury done by the radiation therapy. Another
key factor that significantly impacts the market growth for these drugs include
the fact that the radiation injury can cause reduced production of sperm and
egg count in male and female respectively. 

Full report of Radiation Injury Drugs Market available @ https://www.omrglobal.com/industry-reports/radiation-injury-drugs-market

Market
Coverage

•             Segment Covered- 

o             By Type

o             By Application 

•             Regions covered-

o             North America

o             Europe

o             Asia-Pacific

o             Rest of the World

•             Competitive Landscape:  Amgen
Inc., and BioMimetix JV, LLC, among others.       

Key
questions addressed by the report

•             What is the market growth rate?

•             Which segment and region dominate
the market in the base year?

•             Which segment and region will
project the fastest growth in the market?

•             How COVID-19 impacted the market?

o             Deviation from the pre-COVID-19
forecast

o             Most affected region and segment

•             Who is the leader in the market?

•             How are players addressing
challenges to sustain growth?

•             Where is the investment
opportunity?

Global
Radiation Injury Drugs Market Report by Segment

By
Type

•                
Aerosurf

•                
BMX-001

•                
C-2E2

•                
C-2E5

•                
Des-Asp Angiotensin 1

•                
DG-3

•                
Others

By
Application

•                
Ambulatory Surgical Centers

•                
Hospitals and Clinics

•                
Others

Reasons to Buying From us -



1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after
purchasing your report.

For
More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/radiation-injury-drugs-market

Media Contact:



Contact Person: Mr. Anurag Tiwari

Email: anurag@omrglobal.com

Contact no: +91 780-304-0404

Company Name: Orion Market Research



About Orion Market Research



Orion Market Research (OMR) is a market research and consulting company known
for its crisp and concise reports. The company is equipped with an experienced
team of analysts and consultants. OMR offers quality syndicated research
reports, customized research reports, consulting and other research-based
services. The company also offers Digital Marketing services through its
subsidiary OMR Digital and Software development and Consulting Services through
another subsidiary Encanto Technologies.